UBS’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-4,200
Closed -$166K 10916
2014
Q2
$166K Sell
4,200
-100
-2% -$3.11K ﹤0.01% 5346
2014
Q1
$154K Sell
4,300
-1,800
-30% -$86.2K ﹤0.01% 5493
2013
Q4
$369K Buy
6,100
+5,200
+578% +$282K ﹤0.01% 4635
2013
Q3
$38K Buy
+900
New +$56.4K ﹤0.01% 7223

Other funds holding XONE

UBS's XONE Position: Q3 2014 in Review

UBS increased its The ExOne Company (XONE) stake by 7.5% in Q3 2014, buying an estimated $436K and bringing the position to 204,400 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

UBS first reported a position in XONE in Q2 2013 and has held it in 6 quarters since. The position peaked at $10M in Q4 2013. 88 funds tracked by Wall St. Rank hold XONE as of Q3 2014.

  • UBS held 204,400 shares of The ExOne Company worth $4.27M as of Q3 2014.
  • UBS bought 14,285 The ExOne Company shares in Q3 2014, an estimated $436K.
  • The ExOne Company made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2180 holding.
  • UBS first reported a position in The ExOne Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's The ExOne Company position peaked at $10M in Q4 2013.
  • 88 funds tracked by Wall St. Rank held The ExOne Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.